title: Effect of beta-adrenergic stimulation on the circulatory lymphocyte count: studies in normals and in patients with chronic airflow obstruction.
abstract: In eight non-allergic patients with chronic airflow obstruction (CAO) and eight age and sex matched, healthy control subjects the circadian variation in circulatory lymphocyte count was studied in relation to serum cortisol and urinary epinephrine levels. In addition, we investigated the effect of the beta-adrenergic agent terbutaline on the lymphocyte count in two ways: as a long-term effect after 8 days of oral slow-release terbutaline with constant diurnal and nocturnal serum levels in patients, and as a short-term effect by a constant rate infusion of 0.2 micrograms/min over 4 hr in normals. Both patients and controls showed similar circadian patterns of urinary epinephrine excretion and lymphocyte counts. Patients with CAO, however, had significantly lower epinephrine levels and significantly higher lymphocyte counts at all hours of observation (every 4 hr from 0800 to 0800 hr the next day), as compared with normal controls. After 8 days of slow-release terbutaline the lymphocyte count in the patient group decreased to levels not significantly different from that of normals. The circadian rhythm of the lymphocytes, however, persisted under terbutaline therapy. No correlation existed between the lymphocyte count modulating factor, serum cortisol and the lymphocyte count over 24 hr. On placebo infusion in the control persons an increase of lymphocytes over 4 hr occurred, as a consequence of circadian rhythmicity. On terbutaline infusion a significant increase of lymphocytes after 1 hr was followed by a decrease to levels significantly below those on the placebo day. The same pattern was found in the leucocyte count. From this study it is concluded that beta-adrenergic stimulation corrects the relative lymphocytosis to counts comparable with normals. Other coinciding factors must regulate, however, the circadian rhythmicity.
authors.affiliation: Department of Pulmonology, University Hospital, Groningen, The Netherlands.
authors.forename: D S
authors.initials: DS
authors.lastname: Postma
authors.forename: J J
authors.initials: JJ
authors.lastname: Keyzer
authors.forename: H
authors.initials: H
authors.lastname: Meurs
authors.forename: G H
authors.initials: GH
authors.lastname: Koëter
authors.forename: K
authors.initials: K
authors.lastname: De Vries
authors.forename: H J
authors.initials: HJ
authors.lastname: Sluiter
mesh_terms: D000328:Adult; D001772:Blood Cell Count; D002908:Chronic Disease; D002940:Circadian Rhythm / Q000187:drug effects*; D004837:Epinephrine / Q000652:urine; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000188:drug therapy*; D008214:Lymphocytes / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology*; D013726:Terbutaline / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D011943:Receptors, Adrenergic, beta; D013726:Terbutaline; D006854:Hydrocortisone; D004837:Epinephrine